Mathios, Dimitrios <br/><br/>
Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.  [electronic resource] 

 -  International journal of cancer  Jan 2016 
 - 187-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.29686  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Central Nervous System Neoplasms--immunology<br/>Disease Models, Animal<br/>Female<br/>Glioblastoma--immunology<br/>Humans<br/>Immunologic Memory<br/>Immunotherapy<br/>Interleukin-15--agonists<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Mice<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Proteins--pharmacology<br/>Radiosurgery<br/>Recombinant Fusion Proteins<br/>T-Lymphocyte Subsets--drug effects<br/>Xenograft Model Antitumor Assays